Nexgenrx Inc (NXG_CDNX) earnings
Quarterly and annual NXG_CDNX reports and results, each read against the price at its own news timestamp. Back to the NXG_CDNX overview →
8 measured NXG_CDNX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| NexgenRx Announces Second Quarter Results (With Substantial Increases in Revenue, EBITDA and Financial Position) and Declaration of Dividend | Press release | — | — | |
| NexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA Growth | Press release | — | — | |
| NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA | Press release | — | — | |
| NexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA | Press release | — | — | |
| NexgenRx Announces Third Quarter Results and Declaration of Divdend | Press release | — | — | |
| NexgenRx Announces Second Quarter Results, With Over 19% Revenue Growth and Positive EBITDA | Press release | — | — | |
| NexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record Earnings | Press release | -6.67% | -3.33% | |
| NexgenRx Inc. Announces Q3 2023 Quarterly Results with Continued Revenue Growth and Positive EBITDA | Press release | -4.35% | -4.35% |
Keep exploring
More NXG_CDNX: analyst actions → · SEC filings → · NXG_CDNX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CECORS INC (CEOS) | 22 | -0.33% | 40% |
| H LUNDBECK A/S S/ADR (HLUYY) | 22 | 0.00% | 46% |
| PROCYON CORP (PCYN) | 22 | -2.15% | 0% |
| VivoPower PLC - Ordinary Shares (VIVO) | 22 | -0.39% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.